Compare
Scienture Holdings, Inc. vs Medicinova Inc vs Can-Fite BioPharma Ltd. vs America Great Health
| Latest fiscal year | Scienture Holdings, Inc. SCNX | Medicinova Inc MNOV | Can-Fite BioPharma Ltd. CANF | America Great Health AAGH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-06-30 |
| Revenue | $431.6K | $409.7K | $405.0K | $391.7K |
| Revenue growth (YoY) | +215.9% | n/a | -39.9% | +32.9% |
| Gross margin | 76.8% | n/a | n/a | 86.6% |
| Operating margin | n/m | n/m | n/m | -97.8% |
| Net margin | n/m | n/m | n/m | -183.6% |
| Net income | -$41.51M | -$12.00M | -$9.83M | -$719.1K |
| EPS (Diluted) | -$2.70 | -$0.24 | -$5.97 | $0.00 |
| Operating cash flow | -$13.38M | -$9.81M | -$8.95M | -$332.9K |
| Free cash flow | n/a | -$9.81M | -$8.95M | n/a |
| Cash & equivalents | $6.66M | $30.81M | $5.53M | n/a |
| Total assets | $84.18M | $45.60M | $9.51M | $301.8K |
| Total liabilities | $14.06M | $4.02M | n/a | $6.05M |
| Shareholders' equity | $70.12M | $41.59M | $5.59M | -$5.66M |
| Return on year-end equity | -59.2% | -28.9% | -175.8% | n/a |
| Shares outstanding | 40.63M | 49.22M | 2.62M | 21.15B |
Revenue, most recent five fiscal years
| Fiscal year | Scienture Holdings, Inc. | Medicinova Inc | Can-Fite BioPharma Ltd. | America Great Health |
|---|---|---|---|---|
| Latest | $431.6K Ended 2025-12-31 | $409.7K Ended 2025-12-31 | $405.0K Ended 2025-12-31 | $391.7K Ended 2025-06-30 |
| 1 year earlier | $136.6K Ended 2024-12-31 | n/a | $674.0K Ended 2024-12-31 | $294.7K Ended 2024-06-30 |
| 2 years earlier | $1.36M Ended 2023-12-31 | $1.00M Ended 2023-12-31 | $743.0K Ended 2023-12-31 | $204.3K Ended 2023-06-30 |
| 3 years earlier | $10.25M Ended 2022-12-31 | n/a | $810.0K Ended 2022-12-31 | $104.6K Ended 2022-06-30 |
| 4 years earlier | $9.89M Ended 2021-12-31 | $4.04M Ended 2021-12-31 | $853.0K Ended 2021-12-31 | $195.7K Ended 2021-06-30 |